These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 24664227

  • 1. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
    Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.
    JAMA Neurol; 2014 May; 71(5):543-52. PubMed ID: 24664227
    [Abstract] [Full Text] [Related]

  • 2. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
    Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, Kurlan R, Molho E, Harrison M, Lew M, Parkinson Study Group.
    Arch Neurol; 2002 Oct; 59(10):1541-50. PubMed ID: 12374491
    [Abstract] [Full Text] [Related]

  • 3. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease.
    Yoritaka A, Kawajiri S, Yamamoto Y, Nakahara T, Ando M, Hashimoto K, Nagase M, Saito Y, Hattori N.
    Parkinsonism Relat Disord; 2015 Aug; 21(8):911-6. PubMed ID: 26054881
    [Abstract] [Full Text] [Related]

  • 4. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
    Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, Müller T, Kupsch A, Henningsen H, Oertel WH, Fuchs G, Kuhn W, Niklowitz P, Koch R, Herting B, Reichmann H, German Coenzyme Q(10) Study Group.
    Arch Neurol; 2007 Jul; 64(7):938-44. PubMed ID: 17502459
    [Abstract] [Full Text] [Related]

  • 5. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.
    Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM, NET-PD Investigators.
    JAMA Neurol; 2014 Jun; 71(6):710-6. PubMed ID: 24711047
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S, Parkinson Study Group.
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [Abstract] [Full Text] [Related]

  • 10. Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Negida A, Menshawy A, El Ashal G, Elfouly Y, Hani Y, Hegazy Y, El Ghonimy S, Fouda S, Rashad Y.
    CNS Neurol Disord Drug Targets; 2016 Oct; 15(1):45-53. PubMed ID: 26553164
    [Abstract] [Full Text] [Related]

  • 11. The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials.
    Zhu ZG, Sun MX, Zhang WL, Wang WW, Jin YM, Xie CL.
    Neurol Sci; 2017 Feb; 38(2):215-224. PubMed ID: 27830343
    [Abstract] [Full Text] [Related]

  • 12. Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.
    Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS, Katz J, Rollins Y, Barohn RJ, Jackson CE, Tiryaki E, Lomen-Hoerth C, Armon C, Tandan R, Rudnicki SA, Rezania K, Sufit R, Pestronk A, Novella SP, Heiman-Patterson T, Kasarskis EJ, Pioro EP, Montes J, Arbing R, Vecchio D, Barsdorf A, Mitsumoto H, Levin B, QALS Study Group.
    Ann Neurol; 2009 Aug; 66(2):235-44. PubMed ID: 19743457
    [Abstract] [Full Text] [Related]

  • 13. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
    Wills AM, Pérez A, Wang J, Su X, Morgan J, Rajan SS, Leehey MA, Pontone GM, Chou KL, Umeh C, Mari Z, Boyd J, NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators.
    JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506
    [Abstract] [Full Text] [Related]

  • 14. Does high-dose coenzyme Q10 improve oxidative damage and clinical outcomes in Parkinson's disease?
    Seet RC, Lim EC, Tan JJ, Quek AM, Chow AW, Chong WL, Ng MP, Ong CN, Halliwell B.
    Antioxid Redox Signal; 2014 Jul 10; 21(2):211-7. PubMed ID: 24410614
    [Abstract] [Full Text] [Related]

  • 15. Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease.
    Suzuki M, Yoshioka M, Hashimoto M, Murakami M, Noya M, Takahashi D, Urashima M.
    Am J Clin Nutr; 2013 May 10; 97(5):1004-13. PubMed ID: 23485413
    [Abstract] [Full Text] [Related]

  • 16. CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial.
    Apetauerova D, Scala SA, Hamill RW, Simon DK, Pathak S, Ruthazer R, Standaert DG, Yacoubian TA.
    Neurol Neuroimmunol Neuroinflamm; 2016 Oct 10; 3(5):e266. PubMed ID: 27583276
    [Abstract] [Full Text] [Related]

  • 17. WITHDRAWN: Coenzyme Q10 for Parkinson's disease.
    Liu J, Wang LN, Zhan SY, Xia Y.
    Cochrane Database Syst Rev; 2012 May 16; 2012(5):CD008150. PubMed ID: 22592726
    [Abstract] [Full Text] [Related]

  • 18. [Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?].
    Storch A.
    Nervenarzt; 2007 Dec 16; 78(12):1378-82. PubMed ID: 17508194
    [Abstract] [Full Text] [Related]

  • 19. Coenzyme Q10 for Parkinson's disease.
    Liu J, Wang L, Zhan SY, Xia Y.
    Cochrane Database Syst Rev; 2011 Dec 07; (12):CD008150. PubMed ID: 22161420
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
    Rascol O, Fitzer-Attas CJ, Hauser R, Jankovic J, Lang A, Langston JW, Melamed E, Poewe W, Stocchi F, Tolosa E, Eyal E, Weiss YM, Olanow CW.
    Lancet Neurol; 2011 May 07; 10(5):415-23. PubMed ID: 21482191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.